CollPlant Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:CollPlant Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0136
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant’s wound care products include VergenixFG, Vergenix wound dressing. Its pipeline includes bioink, VergenixTRA, and surgical wounds. CollPlant offers tissue repair products in the areas of orthopedic applications and for advanced wound healing. The company’s products include a surgical matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. It develops regenerative medicine by utilizing proprietary processing technologies based on recombinant human collagen and other proteins. CollPlant is headquartered in Ness Ziona, Israel.

CollPlant Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CollPlant Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CollPlant Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
CollPlant Ltd, Medical Equipment, Deal Details 11
Partnerships 11
CollPlant Enters into Distribution Agreement for Vergenix FG in Turkey 11
CollPlant Enters into Distribution Agreement with Arthrex 12
CollPlant to Enter into Agreement with US based company 13
Equity Offering 14
CollPlant Raises USD2 Million in First Tranche of Private Placement 14
CollPlant Raises USD1.9 Million in Equity Offering 15
CollPlant Files Registration Statement to Raise up to USD25 Million in IPO 16
CollPlant Raises USD3 Million in Equity Offering 17
CollPlant Raises USD2.3 Million in Private Placement of Shares 18
CollPlant Ltd – Key Competitors 19
CollPlant Ltd – Key Employees 20
CollPlant Ltd – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Strategy And Business Planning 22
Apr 23, 2018: CollPlant Opens New rhCollagen Production Facility In Israel 22
May 11, 2017: CollPlant Establishes a Separate Division to Focus on 3D Bio-Printing of Organs and Tissues 23
Financial Announcements 24
May 24, 2018: CollPlant Announces First Quarter 2018 Financial Results 24
Mar 21, 2018: CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update 26
Corporate Communications 28
Jul 05, 2018: CollPlant Names Dr. Wolfgang Ruttenstorfer As Board Director 28
Jun 19, 2018: CollPlant Appoints Professor Shay Soker from Wake Forest Institute for Regenerative Medicine to its Scientific Advisory Board 29
Apr 12, 2018: CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer 30
Jan 16, 2018: CollPlant Appoints David Tsur as Chairman of the Board 31
Legal and Regulatory 32
Jun 26, 2018: CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs 32
Product News 33
May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler 33
Oct 30, 2017: Innovation Authority Gives Vote of Confidence: CollPlant Receives Innovation Authority Approval for USD One Million R&D Program with 40% Funding 34
Other Significant Developments 35
Feb 21, 2018: CollPlant Joins ReMDO’s Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs 35
Nov 28, 2017: CollPlant Receives Substantial, Repeat Order for Its Biological Ink 36
May 31, 2017: CollPlant Provides Operational Update for Q1 2017 37
Mar 30, 2017: CollPlant Provides Commercial and Operational Update 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
CollPlant Ltd, Medical Equipment, Key Facts 2
CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CollPlant Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CollPlant Ltd, Deals By Market, 2012 to YTD 2018 9
CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
CollPlant Enters into Distribution Agreement for Vergenix FG in Turkey 11
CollPlant Enters into Distribution Agreement with Arthrex 12
CollPlant to Enter into Agreement with US based company 13
CollPlant Raises USD2 Million in First Tranche of Private Placement 14
CollPlant Raises USD1.9 Million in Equity Offering 15
CollPlant Files Registration Statement to Raise up to USD25 Million in IPO 16
CollPlant Raises USD3 Million in Equity Offering 17
CollPlant Raises USD2.3 Million in Private Placement of Shares 18
CollPlant Ltd, Key Competitors 19
CollPlant Ltd, Key Employees 20

List of Figures
CollPlant Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CollPlant Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CollPlant Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[CollPlant Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Huawei Technologies Co Ltd:企業の戦略的SWOT分析
    Huawei Technologies Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Qatar Airways Group Q.C.S.C.
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Plava Laguna dd:企業の戦略・SWOT・財務情報
    Plava Laguna dd - Strategy, SWOT and Corporate Finance Report Summary Plava Laguna dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Alliqua BioMedical Inc (ALQA):製薬・医療:M&Aディール及び事業提携情報
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s products comprise ultrasound healing therapy, human biologics, antimicrobial protecti …
  • Santhera Pharmaceuticals Holding AG (SANN):製薬・医療:M&Aディール及び事業提携情報
    Summary Santhera Pharmaceuticals Holding AG (Santhera) develops and commercializes novel pharmaceutical products indicated for patients with mitochondrial and neuromuscular diseases. It specifically focuses in the area of neuromuscular and neuro-ophthalmological conditions. The company’s lead produc …
  • Intezyne Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Intezyne Inc (Intezyne) is a biotechnology company that develops product candidates for the treatment of various cancer tumors. The company offers anti-cancer agents and IVECT method to improve cancer therapy. It provides compounds that are cellular or molecularly targeted or have tumor-spec …
  • Ferguson Plc:企業のM&A・事業提携・投資動向
    Ferguson Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ferguson Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • IMPARAT Farbwerk Iversen & Mahl GmbH & Co KG:企業の戦略・SWOT・財務情報
    IMPARAT Farbwerk Iversen & Mahl GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary IMPARAT Farbwerk Iversen & Mahl GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Kentucky Power Co:発電所・企業SWOT分析
    Kentucky Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Otto Bock HealthCare GmbH:企業の戦略的SWOT分析
    Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • freenet AG:企業のM&A・事業提携・投資動向
    freenet AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's freenet AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • NuSirt Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuSirt Biopharma Inc (NuSirt Sciences) develops a technology platform that combines natural compounds with various pharmaceutical agents to prevent and treat chronic diseases resulting from over-nutrition and aging. Its technology platform focuses on activating sirtuin pathways through the a …
  • PTC India Ltd (PTC):電力:M&Aディール及び事業提携情報
    Summary PTC India Ltd (PTC) formerly Power Trading Corporation of India Limited, is a provider of power trading solutions. The company is a public-private partnership entity initiated by the government of India. It carries out trading activities which include, long term trading of power generated fr …
  • Amneal Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Amneal Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amneal Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Hoosier Energy Rural Electric Cooperative, Inc.:発電所・企業SWOT分析
    Hoosier Energy Rural Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, …
  • Vista Gold Corp.:企業の戦略・SWOT・財務情報
    Vista Gold Corp. - Strategy, SWOT and Corporate Finance Report Summary Vista Gold Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務情報
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Center for Applied Medical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary Center for Applied Medical Research (CIMA), a subsidiary of University of Navarra, is a medical research center that carries out research in the therapeutic areas of cardiovascular sciences, gene therapy and hepatology, oncology and neurosciences. The center also offers support services such …
  • Open Monoclonal Technology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Open Monoclonal Technology Inc (OMT), a subsidiary of Ligand Pharmaceuticals Inc, is a biotechnology company that discovers and develops human monoclonal antibody platform based on transgenic rats. The company provides products such as omnirat, omnimouse and omniflic. Its omnirat is an antib …
  • Southwest Gas Holdings Inc:企業の戦略・SWOT・財務情報
    Southwest Gas Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Southwest Gas Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆